| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/14/2008 | US20080039482 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039473 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/14/2008 | US20080039467 Method For The Prevention Of Thromboembolic Disorders |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039455 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039435 Novel Steroid Agonist For Fxr |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039395 Methods for treating septic shock |
| 02/14/2008 | US20080039391 such as dabigatran etexilate; immobilized patients, congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant women |
| 02/14/2008 | US20080039390 Use of the insulin-like-growth factor I splice variant MGF for the prevention of myocardial damage |
| 02/14/2008 | US20080039388 Derived from the chain of the (B)beta(15-42)-fibrin fragment substituted by genetically encoded or not genetically encoded amino acids or peptidomimetics; cysteine modified by succinimido-polyoxyethylene glycol; antiinflammatory agents; endothelium stabilizers |
| 02/14/2008 | US20080039382 Compositions related to pleiotrophin methods and uses thereof |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039376 Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof |
| 02/14/2008 | US20080039367 Medicinal Composition Containing Diabeted Remedy |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038380 Acorus Gramineus Soland Extract for Preventing and Treating Ischemic Heart Disease and Pharmaceutical Composition and Health Food Containing the Same |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038346 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038342 Stable Pharmaceutical Composition Comprising an Ace Inhibitor |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038310 Coating comprising an elastin-based copolymer |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | DE102006037920A1 Spezielle Carbonylbisimino-Verbindungen zur Behandlung von Immunerkrankungen Carbonylbisimino specific compounds for the treatment of immune diseases |
| 02/14/2008 | CA2660538A1 Nitrate esters of piperidines |
| 02/14/2008 | CA2660235A1 Therapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 02/14/2008 | CA2660186A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1887005A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1886692A1 Agent for improvement of insulin resistance |
| 02/13/2008 | EP1886691A2 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
| 02/13/2008 | EP1886689A1 Oxidative stress inhibitor |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886678A1 Stable tablet containing droxidopa |
| 02/13/2008 | EP1885872A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885739A2 Method of inhibiting intimal hyperplasia |
| 02/13/2008 | EP1885724A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885697A2 Soluble epoxide hydrolase inhibitors and methods of using same |
| 02/13/2008 | EP1885694A2 4-biarylyl-1-phenylazetidin-2-ones |
| 02/13/2008 | EP1885455A1 Delivery systems |
| 02/13/2008 | EP1885382A2 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 02/13/2008 | EP1885361A2 Acyl hydrazones for treating cardiovascular diseases |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1536796B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/13/2008 | EP1517883B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1411923B1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | EP1297843B1 Method of photoreduction of hemoglobin vesicles |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | EP1233770B1 Phosphonate compounds |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | CN201019997Y Outer hemorrhoid atomization hip bath instrument |
| 02/13/2008 | CN101124204A Amorphous lercanidipine hydrochloride |
| 02/13/2008 | CN101121696A Metal salt of pyritinol and hydrate of the same |
| 02/13/2008 | CN101121011A Method for treating coronary heart disease and angina pectoris |
| 02/13/2008 | CN101121003A Vinegar with disease treating function and manufacturing method thereof |
| 02/13/2008 | CN101121002A Chinese preparatory medicine for treating high blood pressure and cardiovascular and cerebrovascular diseases |
| 02/13/2008 | CN101120995A Method for making traditional Chinese medicine decoction for treating serious edema caused by pulmonary heart disease |
| 02/13/2008 | CN101120978A Thrombus granule and preparing method thereof |
| 02/13/2008 | CN101120972A Traditional Chinese medicine for treating angina pectoris |
| 02/13/2008 | CN101120965A Application of 20(S)-ginsenoside Rh2 in preparing medicine for reducing cardiotoxicity caused by doxorubicin |
| 02/13/2008 | CN101120949A Traditional Chinese medicine for treating haemorrhoids |
| 02/13/2008 | CN101120944A Composition containing inhibitor of thromboxane synthetase and nitrate esters medicine |
| 02/13/2008 | CN101120942A Compound medicine preparation for treating cardiac and cerebral vascular diseases |
| 02/13/2008 | CN101120939A Medicinal composition containing nitrate esters for treating ventricular hypertrophy or myocardial fibrosis |
| 02/13/2008 | CN101120924A Calf serum protein-removing extract for injection and its preparation method |
| 02/13/2008 | CN101120789A Method for producing instant powder of cactus |
| 02/13/2008 | CN100368550C High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368374C Carboxylic compound and medicine comprising the same |
| 02/13/2008 | CN100368373C Carboxyl substituted resveratrol analog compound and its preparation method |
| 02/13/2008 | CN100368005C Chinese medicine preparation for treating coronary heart disease and angina pectoris and its preparing method |